• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床分离的鲍曼不动杆菌中 AdeABC 外排泵的过度表达与替加环素耐药相关。

Overexpression of AdeABC efflux pump associated with tigecycline resistance in clinical Acinetobacter nosocomialis isolates.

机构信息

Division of Infectious Diseases and Tropical Medicine, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.

Department of Medical Techniques, Taipei City Hospital Ren-Ai Branch, Taipei, Taiwan.

出版信息

Clin Microbiol Infect. 2019 Apr;25(4):512.e1-512.e6. doi: 10.1016/j.cmi.2018.06.012. Epub 2018 Jun 12.

DOI:10.1016/j.cmi.2018.06.012
PMID:29906589
Abstract

OBJECTIVES

Tigecycline non-susceptible Acinetobacter nosocomialis (TNAN) has been discovered in clinical isolates. The resistance-nodulation-cell division (RND)-type efflux system plays a major role in tigecycline non-susceptible Acinetobacter baumannii, but the mechanism in A. nosocomialis remains unknown. Our aim was to analyse the contribution of efflux-based tigecycline resistance in clinical A. nosocomialis isolates collected from multiple medical centres in Taiwan.

METHODS

A total of 57 A. nosocomialis isolates, including 46 TNAN and 11 tigecycline-susceptible A. nosocomialis (TSAN) isolates, were analysed. Of these, 46 TNAN isolates were clustered to ST410 (43 isolates) and ST68 (three isolates) by multi-locus sequence typing.

RESULTS

The relationship between the RND efflux pump and tigecycline resistance was indirectly verified by successfully reducing tigecycline resistance with NMP, an efflux pump inhibitor. The three RND efflux systems (AdeABC, AdeIJK and AdeFGH) were detected in all clinical isolates. The transcript level of adeB gene increased significantly and was correlated with tigecycline resistance. Moreover, the AdeRS two-component system was further classified into four different types of AdeRS patterns considering the amino acid sequence. Further analysis showed that tigecycline resistance was related to the transcript level of adeB gene and the AdeRS pattern.

CONCLUSION

This study showed that the dissemination of TNAN isolates in Taiwan is attributable mainly to the spread of ST410. The AdeABC efflux pump appeared to play an important role in the tigecycline resistance of A. nosocomialis.

摘要

目的

已在临床分离株中发现不敏感替加环素的医院不动杆菌(TNAN)。 耐药-结节-分裂(RND)型外排系统在不敏感的鲍曼不动杆菌中对替加环素的耐药性起着重要作用,但在医院不动杆菌中的机制尚不清楚。我们的目的是分析从台湾多个医学中心收集的临床分离的医院不动杆菌中基于外排的替加环素耐药性的贡献。

方法

共分析了 57 株医院不动杆菌分离株,包括 46 株 TNAN 和 11 株替加环素敏感的医院不动杆菌(TSAN)分离株。其中,46 株 TNAN 分离株通过多位点序列分型聚类为 ST410(43 株)和 ST68(3 株)。

结果

成功用外排泵抑制剂 NMP 间接证实了 RND 外排泵与替加环素耐药性之间的关系,从而降低了替加环素的耐药性。所有临床分离株均检测到三种 RND 外排系统(AdeABC、AdeIJK 和 AdeFGH)。adeB 基因的转录水平显著增加,并与替加环素耐药性相关。此外,考虑到氨基酸序列,AdeRS 双组分系统进一步分为四种不同类型的 AdeRS 模式。进一步分析表明,替加环素耐药性与 adeB 基因转录水平和 AdeRS 模式有关。

结论

本研究表明,台湾 TNAN 分离株的传播主要归因于 ST410 的传播。AdeABC 外排泵似乎在医院不动杆菌对替加环素的耐药性中起着重要作用。

相似文献

1
Overexpression of AdeABC efflux pump associated with tigecycline resistance in clinical Acinetobacter nosocomialis isolates.临床分离的鲍曼不动杆菌中 AdeABC 外排泵的过度表达与替加环素耐药相关。
Clin Microbiol Infect. 2019 Apr;25(4):512.e1-512.e6. doi: 10.1016/j.cmi.2018.06.012. Epub 2018 Jun 12.
2
RND-type efflux pumps in multidrug-resistant clinical isolates of Acinetobacter baumannii: major role for AdeABC overexpression and AdeRS mutations.鲍曼不动杆菌多药耐药临床分离株中的 RND 型外排泵:AdeABC 过度表达和 AdeRS 突变的主要作用。
Antimicrob Agents Chemother. 2013 Jul;57(7):2989-95. doi: 10.1128/AAC.02556-12. Epub 2013 Apr 15.
3
AdeABC Efflux Pump Controlled by AdeRS Two Component System Conferring Resistance to Tigecycline, Omadacycline and Eravacycline in Clinical Carbapenem Resistant .由AdeRS双组分系统控制的AdeABC外排泵赋予临床耐碳青霉烯类菌对替加环素、奥马环素和依拉环素的耐药性
Front Microbiol. 2020 Nov 2;11:584789. doi: 10.3389/fmicb.2020.584789. eCollection 2020.
4
AdeRS combination codes differentiate the response to efflux pump inhibitors in tigecycline-resistant isolates of extensively drug-resistant Acinetobacter baumannii.AdeRS组合编码可区分广泛耐药鲍曼不动杆菌对替加环素耐药菌株中流出泵抑制剂的反应。
Eur J Clin Microbiol Infect Dis. 2014 Dec;33(12):2141-7. doi: 10.1007/s10096-014-2179-7. Epub 2014 Jun 18.
5
The role of RND efflux pump and global regulators in tigecycline resistance in clinical Acinetobacter baumannii isolates.RND外排泵和全局调控因子在临床鲍曼不动杆菌分离株对替加环素耐药中的作用
Future Microbiol. 2015;10(3):337-46. doi: 10.2217/fmb.15.7.
6
Mechanisms of carbapenem resistance in Acinetobacter pittii and Acinetobacter nosocomialis isolates from Thailand.泰国鲍曼不动杆菌和医院不动杆菌分离株碳青霉烯类耐药机制研究。
J Med Microbiol. 2018 Dec;67(12):1667-1672. doi: 10.1099/jmm.0.000845. Epub 2018 Oct 12.
7
AdeABC multidrug efflux pump is associated with decreased susceptibility to tigecycline in Acinetobacter calcoaceticus-Acinetobacter baumannii complex.AdeABC多药外排泵与醋酸钙不动杆菌-鲍曼不动杆菌复合体对替加环素的敏感性降低有关。
J Antimicrob Chemother. 2007 May;59(5):1001-4. doi: 10.1093/jac/dkm058. Epub 2007 Mar 15.
8
Contribution of resistance-nodulation-cell division efflux systems to antibiotic resistance and biofilm formation in Acinetobacter baumannii.耐药-固氮-细胞分裂外排系统对鲍曼不动杆菌抗生素耐药性和生物膜形成的作用
mBio. 2015 Mar 24;6(2):e00309-15. doi: 10.1128/mBio.00309-15.
9
Tigecycline Heteroresistance and Resistance Mechanism in Clinical Isolates of Acinetobacter baumannii.替加环素异质性耐药和鲍曼不动杆菌临床分离株的耐药机制。
Microbiol Spectr. 2021 Oct 31;9(2):e0101021. doi: 10.1128/Spectrum.01010-21. Epub 2021 Sep 15.
10
Prevalence of RND efflux pump regulator variants associated with tigecycline resistance in carbapenem-resistant Acinetobacter baumannii from a worldwide survey.全球调查中耐碳青霉烯鲍曼不动杆菌中与替加环素耐药相关的 RND 外排泵调节剂变异体的流行率。
J Antimicrob Chemother. 2021 Jun 18;76(7):1724-1730. doi: 10.1093/jac/dkab079.

引用本文的文献

1
Targeting Acinetobacter baumannii resistance-nodulation-division efflux pump transcriptional regulators to combat antimicrobial resistance.靶向鲍曼不动杆菌耐药-结瘤-分裂外排泵转录调节因子以对抗抗菌药物耐药性。
NPJ Antimicrob Resist. 2025 Jan 25;3(1):4. doi: 10.1038/s44259-024-00074-z.
2
The tigecycline resistance mechanisms in Gram-negative bacilli.革兰氏阴性杆菌中替加环素的耐药机制。
Front Cell Infect Microbiol. 2024 Nov 20;14:1471469. doi: 10.3389/fcimb.2024.1471469. eCollection 2024.
3
Comparison of antimicrobial activities and resistance mechanisms of eravacycline and tigecycline against clinical isolates in China.
依拉环素与替加环素对中国临床分离株的抗菌活性及耐药机制比较
Front Microbiol. 2024 Sep 24;15:1417237. doi: 10.3389/fmicb.2024.1417237. eCollection 2024.
4
Emergence of eravacycline heteroresistance in carbapenem-resistant isolates in China.厄他培南耐药碳青霉烯类耐药株中出现依拉环素异质性耐药。
Front Cell Infect Microbiol. 2024 Mar 27;14:1356353. doi: 10.3389/fcimb.2024.1356353. eCollection 2024.
5
Promoter regulatory mode evolution enhances the high multidrug resistance of .启动子调控模式进化增强了. 的多药耐药性。
mBio. 2024 May 8;15(5):e0021824. doi: 10.1128/mbio.00218-24. Epub 2024 Apr 2.
6
A preliminary exploration on the mechanism of the carbapenem-resistance transformation of Serratia marcescens in vivo.体内阴沟肠杆菌碳青霉烯类耐药性转化机制的初步探索。
BMC Genomics. 2024 Jan 2;25(1):2. doi: 10.1186/s12864-023-09904-2.
7
Efflux Pumps and Different Genetic Contexts of (X4) Contribute to High Tigecycline Resistance in from Pigs.外排泵和(X4)的不同遗传背景导致猪源 对替加环素的高度耐药性。
Int J Mol Sci. 2023 Apr 8;24(8):6923. doi: 10.3390/ijms24086923.
8
The frequency of efflux pump genes expression in Acinetobacter baumannii isolates from pulmonary secretions.从肺分泌物中分离的鲍曼不动杆菌菌株中外排泵基因的表达频率。
AMB Express. 2022 Aug 4;12(1):103. doi: 10.1186/s13568-022-01444-4.
9
Differential Binding of Carbapenems with the AdeABC Efflux Pump and Modulation of the Expression of AdeB Linked to Novel Mutations within Two-Component System AdeRS in Carbapenem-Resistant Acinetobacter baumannii.碳青霉烯类药物与 AdeABC 外排泵的差异结合及其与新型突变的关系,两组分系统 AdeRS 对鲍曼不动杆菌碳青霉烯类耐药性的调节。
mSystems. 2022 Aug 30;7(4):e0021722. doi: 10.1128/msystems.00217-22. Epub 2022 Jun 23.
10
Virulence Potential and Treatment Options of Multidrug-Resistant (MDR) .多重耐药(MDR)的毒力潜能及治疗选择
Microorganisms. 2021 Oct 6;9(10):2104. doi: 10.3390/microorganisms9102104.